ASMF: Two API Manufacturing Sites Listed - Only One to Be Registered?
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The Q&A document "QP Declaration" of the CMDh, last revised in December 2018, was updated again in July 2020. Question No. 5, which previously referred to CEPs (Certificates of Suitability of Monographs of the European Pharmacopoeia), has been extended and is now also valid for ASMFs (Active Substance Master Files).
Accordingly, ASMFs that list two different manufacturing sites for the production of an API, but only one of these manufacturing sites is to be registered, require a QP Declaration only for this manufacturing site. In addition, it must be documented that the API is produced exclusively in the same manufacturing site. If the second production site is to be added at a later date, this must be done via a variation and also requires a QP Declaration.
The Q&A document "QP Declaration" including updates can be found on the HMA (Heads of Medicines Agencies) website in the section "CMDh". General information on "How to submit an Active Substance Master File?" can be found here.
Related GMP News
21.10.2026EMA Clarifies ESMP Reporting for Critical Medicine Shortages
20.10.2026EDQM Updates Guidance on CEP Sister File Applications
20.10.2026EDQM Revises Guidance on Electronic Submissions for CEP Applications
14.10.2026Bioassays in the United States Pharmacopoeia - Two Chapters come into Force in Spring
07.10.2026CEP 2.0: EDQM Updates Guidance on the Use of Certificates of Suitability
23.09.2026IRIS Portal: EMA expands digital Procedure Management